Neoplasia and Internal Environment by Bielschowsky, F.
80
NEOPLASIA AND INTERNAL ENVIRONMENT.
F. BIELSCHOWSKY.
Hugh Adam Cancer Research Department of the Medical School and the
New Zealand Branch of the British Empire Cancer Campaign,
University ofOtago, Dunedin, New Zealand.
Received for publication January 1, 1955.
CONTENTS.
I. INTRODUCTION
II. THE ROLE OF THYROID AND PITUITARY HORMONES IN THE INITIATION OF
CHEMICALLY INDUCED TUMOURS
III. THE ROLE OF THYROID HORMONE DEFICIENCY IN TUMOURIGENESIS IN
THYROID AND PITUITARY
1. Thyroid Tumours Induced by Goitrogen in Rats
2. Thyroid Tumours Induced by Goitrogen in Mice
3. Thyroid Tumours Induced by I131 in Rats
4. Thyroid Tumours Induced by I31 in Mice
5. Thyroid Tumours Due to Iodine Deficiency
6. Thyroid Tumours in Intraspleenic Grafts
7. Functional Activity ofThyroid Tumours
8. Pituitary Tumours
9. Cancers of the Human Thyroid
10. Experimental Thyroid Tumours, an Example for Responsive
Tumours
IV. RETROGRESSION OF TUMOURS
1. Spontaneous Regressions
2. Morphology of Spontaneous Regression
(a) Conditioned Growths
(b) Malignant Growths
3. Morphology of Induced Regression
(a) By Oestrogens in Mammary Cancers
(b) By Oestrogens in Prostatic Cancers
(c) By Progesterone in Cancer of the Cervix
(d) By Other Means
4. Changes in Endocrine Organs ofPatients Suffering from Malignant
Disease
5. Discussion
6. Regression Induced by Immunological Reactions
REFERENCES
I. INTRODUCTION.
DURING the last fifteen years it has been generally recognised that the growth
oftumours depends not only on the intrinsic properties ofneoplastic cells but also
on the environment in which they develop. Of the morphogenetic factors activeNEOPLASIA AND INTERNAL ENVIRONMENT
in post-embryonic life only the secretions of endocrine glands have been identified
so far. When speaking of internal environment in connection with normal or
neoplastic growth one refers to variations in hormone levels. As will be shown,
the reaction to an exogenous carcinogenic agent can be profoundly altered by a
hormonal deficiency. Variations in hormone level can be the essential factor
for the development of some tumours and such changes can, in certain circum-
stances, lead to retrogression of a cancer. In Section II the recent investigations
into the response ofhypophysectomized or thyroidectomized rodents to chemical
carcinogens will be discussed. In the third section the neoplasms found in thyroid
hormone deficient rats and mice will be reviewed and their relationship to human
thyroid cancers discussed. Section IV deals with retrogression of malignant
growths with special emphasis on the morphology of human cancers regressing
under the influence of changes in the hormonal environment.
II. THE ROLE OF HORMONES IN THE INITIATION OF CHEMICALLY INDUCED
TUMOURS.
Many organs cannot maintain their size in the absence ofhormones. on which
they depend for their normal development and function. Generally it is difficult
to induce neoplastic growths in atrophic tissues such as the breast of a rodent
ovariectomized early in life. Only with the aid of massive doses of some of the
most powerful carcinogenic hydrocarbons a pathological growth response can be
occasionally obtained (Shay, Harris and Gruenstein, 1952). In the experiments
to be discussed this type ofatrophy can be ruled out as a major factor responsible
for the failure ofthe carcinogen to act in its usual manner.
Moon, Simpson and Evans (1952) implanted pellets of methycholanthrene into
the gastrocnemius of 15 hypophysectomized rats and saw only 1 sarcoma during
the 316 days of observation. Twelve rapidly progressing cancers developed in
the 15 intact controls. Griffin, Rinfret and Corsigilia (1953) fed a diet containing
3-methyl-4-dimethylaminoazobenzene to 18 hypophysectomized rats of two
different strains for periods up to 19 weeks. The only pathological change ob-
served was a mild cirrhosis in the liver of one of them. Multiple hepatomas
appeared already during the 14th week in the intact controls. It is astonishing
that two animals in which approximately 25 per cent of the pituitary were still
present showed no signs of neoplasia in the liver but only cirrhosis. In a later
communication, Richardson, Griffin and Rinfret (1953) described the histology of
24 completely and 2 incompletely hypophysectomized rats treated with the same
carcinogenic azo dye. The livers of the former were normal in every respect but
those of the latter showed the usual cirrhosis, proliferation of bile ducts, fatty
changes and beginning neoplastic growth. Study of the adrenal glands of the
experimental animals led the authors to suggest that "some factor elaborated
by the pituitary is essential for adrenal-lipoid maintenance and subsequent
cancer formation". However, their preliminary results with crude gonadotrophin
fractions are difficult to reconcile with this contention (Griffin, Rinfret, Robertson
and O'Neal, 1953).
Bielschowsky and Hall (1953) gave an account of the tumours which can be
induced in thyroidectomized rats with 2-aminofluorene (AF) or its monoacetyl
derivative (AAF). Only the results obtained with the amine will be quoted in
detail. No liver tumour was found in 20 completely thyroidectomized rats,
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whereas 6 of the 10 partially thyroidectomized animals and 16 of the 18 intact
controls had hepatomas. Reduction in the incidence ofliver tumours induced
by AAF in rats treated with thiouracil had been reported by Paschkis, Cantarow
and Stasney (1948) and by Leathem and Barken (1950). The Philadelphia group
found that under the influence of the goitrogen the percentageof hepatomas in
males dropped from 83.6 to 20.2 and in the females from 46 per cent to zero.
Leatham and Barken repeated this experiment with pair-fed rats and thus elimin-
ated the possible effect ofreduced food intake. After 8 months 50 per cent of the
animals receiving the carcinogen alone hadliver cancers and the rest benign
cystic cholangiomas. Only one of the 8 males receiving AAF and thiouracil
developed a hepatoma, but 6 had cystic lesions in the liver. Paschkis, Cantarow
and Stasney (1948) included in their paper an experiment in which para-dimethyl-
aminoazobenzene was used as carcinogen. In the males thiouracil did not modify
the action of the azo dye, but it lowered the incidence of liver tumours in the
females from 88 to 46 per cent. There exists therefore evidence that thyroid
hormone deficiency modifies the response oftheliver cells against AF andAAF and,
perhaps, against butter yellow. In the writer's experience the degree of thy-
roxine deficiency is crucial for the outcome of the experiment. Animals, the
pituitary of which still contained acidophilic cells in appreciable numbers, always
showed the typical liver lesions which follow the administration of the aromatic
amine. Rats with pituitaries void of acidophils, i.e. animals in which only traces
ofthyroxine could still be present in thebody, had livers free ofneoplastic changes.
It should be kept in mind that a severe degree of thyroxine deficiency implies
lack of growth hormone. The endocrine imbalance is rather complex since
adrenals and gonads too are affected by complete thyroidectomy. However,
gonadectomy gives only a very slight protection against the hepatoma-inducing
action of AAF. From the studies on tumour induction by AF and AAF in
thyroxine deficient animals it became evident that the protection given by thy-
roidectomy was restricted to the liver, whereas the susceptibility of the sebaceous
glands of the meatus acousticus externus was not affected and that of the retro-
bulbar glands was even increased.
Richardson, Griffin and Rinfret (1953), as well as the writer, were impressed
by the absence of the expected signs of liver damage in the hypophysectomized
or thyroidectomized rats treated with carcinogens which have a predelection for
the liver. The amounts of the carcinogenic agents given in these experiments
always induce liver damage in intact animals. In my experiments the only
abnormality noted was the occasional occurrence of highly vacuolated liver cells.
It is known that thyroxine deficiency modifies the reaction of the liver to dietary
injury (Gyorgy and Goldblatt, 1945; Handler and Follis, 1948; Sellers and You,
1951). L6ger, Masson and Prado (1947) observed that removal of the thyroid
increased the resistance of the rat to the egg-white reaction. No satisfactory
explanation can be offered at present as to the mechanism by which thyroxine
deficiency protects the liver against injury of widely different etiology. The
results obtained with carcinogenic agents are in line with the old conception of a
causal connection between liver cell damage and hepatoma formation, which is
further strengthened by the observation that thyroidectomy performed once
AAF has produced liver cell damage, does not arrest the development of neo-
plastic growth.
The skin seems to be an organ in which hormone deficiency does not greatly
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modify the reaction to chemical carcinogens. Korteweg and Thomas (1939)
studied the action of 3,4-benzpyrene on the skin ofhypophysectomized mice. In
one experiment the interval between operation and the start of painting the skin
was 4 weeks, in another 5-7-months-old animals were used hypophysectomized
at the age of 6 weeks. Skin tumours developed in all the control animals, papil-
lomas appearing 44-100 days and carcinomas 93-104 days after onset oftreatment.
All of the 14 hypophysectomized mice still alive when the first papilloma was
found on the 105th day of the experiment developed tumours of the skin; ten of
them became cancerous between the 121st and 190th day. Although carcino-
genesis was retarded in the hypophysectomized mice, the response of their skin
to benzpyrene was qualitatively the same. Hall and Bielschowsky (unpublished
results) repeated the work of Korteweg and Thomas (1939) using methylchol-
anthrene as carcinogen and restricting the application of this compound to 23
paintings. Our results are in excellent agreement with those of the Dutch
workers. Benign and malignant tumours of the epidermis appeared after the
administration of methylcholanthrene had been terminated in completely hypo-
physectomized mice showing the typical atrophy of the gonads and all the other
morphological signs of pituitary deficiency. The neoplasms, however, developed
slower than in the controls. One melanoma was found in a completely hypo-
physectomized female.
The histology ofthe reaction ofmuscle and connective tissue to methylcholan-
threne in the hypophysectomized rat has not yet been described. The few data
available indicate that once a hydrocarbon has induced a sarcoma, hypophy-
sectomy will only retard its growth (Ball and Samuels, 1936). In the case of the
liver of thyroidectomized rats the carcinogen apparently fails to change normal
into neoplastic cells, i.e. the initiation of the neoplastic process is inhibited.
There is some suggestive evidence that other factors may be involved. Hypo-
physectomy seemingFy does not affect the skin and its appendages to judge from
the good condition of the fur and the rapid regrowth of clipped hairs in mice.
Zeckwer (1953) noted that in the adrenalectomized rat regrowth of hair was even
accelerated. Fraser and Nay (1953) observed a similar effect in ovariectomized
mice, but inhibition of hair-growth towards the end of pregnancy, confirming
earlier findings of the inhibitory action of elevated doses of oestrogen. In this
connection recent results of Engelbreth-Holm and Jensen (1953) are relevant.
The injection of growth hormone into mice failed to alter the incidence of skin
tumours induced by a single application of 9,10-dimethyl, 1,2-benzanthracene.
The only effect noted was a delayed appearance of neoplasms in the injected
animals. From such observations and those of Korteweg and Thomas (1939) it
seems that hormones have but little influence on the normal and neoplastic
growth processes in the epidermis. On the other hand there is ample evidence
that pituitary secretions can influence the growth of liver and of subcutaneous
tissues as seen in acromegaly or after the injection of crude pituitary extracts.
III. THE ROLE OF THYROID HORMONE DEFICIENCY IN TUMOURIGENESIS IN
THYROID AND PITUITARY.
During the last decade benign and malignant neoplasms of the thyroid of
rats and mice have been obtained by various means. The conditions under
which they occur are: (1) After administration ofgoitrogenic substances alone or
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in combination with carcinogens. (2) After administration of radio-iodine alone
or in combination with goitrogens or acetlyaminofluorene. (3) After feeding an
iodine deficient diet, and (4), possibly, after transplantation of thyroid grafts
into the spleen.
1. Thyroid Tumours Induced by Goitrogens in Rats.
In the course of their systematic studies on experimental goitre Griesbach,
Kennedy and Purves (1945) encountered neoplastic lesions in the thyroids of
rats which had been kept for prolonged periods on regimens containing 45 per
cent rape seed, the goitrogenic action of which had been discovered by
Hercus and Purves (1936). After uninterrupted feeding of such diets single or
multiple nodules of macroscopic size were present in the hyperplastic, hyperaemic
glands, the first adenoma appearing in a rat receiving an iodine-poor rape seed
ration for 8 months. The incidence of tumours rose to 80 per cent after 18 and
to 100 per cent after 24 months. A supplement of iodine given to one group
reduced the degree of hyperplasia in the thyroid, but had no influence on the
number of thyroid tumours present in rats kept for 15 or more months on this
regimen. None of the neoplastic lesions discovered in the thyroids of rats on
the brassica-seed rations showed the morphological signs of malignancy, but one
carcinoma of the thyroid developed in one of 10 animals receiving an iodine-poor
control diet. The rats of the local colony were found to be more susceptible to
thegoitrogenic effect ofrape seed than Wistar rats obtained from outside. Repeat-
ing this experiment with thiourea as goitrogenic agent Purves and Griesbach
(1946) found 2 carcinomas in 30 rats, all of which had adenomatous thyroids.
The diagnosis adenocarcinoma was based on the presence of multiple metastases
in the lungs. In their next publication Purves and Griesbach (1947) amplified
these findings and recorded the presence of 7 adenocarcinomas in 13 rats treated
for 20 months with thiourea. Being familiar with the morphological changes
occurring in the pituitary after administration ofgoitrogens, correctly interpreted
by the New Zealand workers (Griesbach, 1941; Griesbach and Purves, 1945) as
indicating stimulation of the thyrotrophic hormone (TSH) secreting basophils
in response to thyroid hormone (TH) deficiency, Griesbach, Kennedy and Purves
(1945) concluded that the thyroid tumours were the result of prolonged stimula-
tion by TSH.
In 1944 the writer described the induction of tumours of the thyroid of rats
by the simultaneous administration of a goitrogen, allylthiourea (Kennedy, 1942)
and of a carcinogen, 2-acetylaminofluorene (AAF). The earliest neoplastic
changes were seen in the thyroid ofan animal killed on the 197th day ofthe experi-
ment and one month later all rats had multiple adenomas. Two of the lesions
were considered malignant because the neoplasms had invaded neighbouring
structures. No adenomas were found in the control group treated with allyl-
thiourea alone, nor have I ever observed thyroid tumours in rats with non-stimu-
lated thyroids after treatment with AAF. However Armstrong and Bonser
(1947) found two thyroid cancers and one colloid goitre in mice treated with this
carcinogen and Cox, Wilson and DeEds (1947) 11 thyroid tumours in 84 rats.
In continuation of his studies the writer (1945) tested the action of allylthiourea
on the thyroid ofrats treated previously for 25 weeks with AAF. After ten weeks
ofgoitrogenic stimulation multiple adenomas were already present in the thyroids.
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Of the 11 controls treated with allylthiourea alone for 6-14 weeks, 4 had minute
adenomas, discovered by serial sectioning ofthe glands. Repetition ofthe experi-
ment using piebald rats and reducing the administration of the carcinogen to
15 weeks, led again to the formation of multiple thyroid adenomas in most of
the animals after 10 or more weeks of treatment with the goitrogen. No aden-
omas were found in the controls-proof that this strain was less sensitive to goit-
rogens than the Wistar rats used in previous experiments. In the same paper
the fate of the single adenomas induced by allylthliourea in Wistar rats was
described, the animals being killed 2-8 weeks after withdrawal of the goitrogen.
The changes were identical with those observed by Griesbach et al. (1945) after
the administration of physiological doses of thyroxine for 3 weeks. The tumour
epithelium changed from tall cylindrical to a low cuboid type and colloid accu-
mulated in the nodules. It is of interest that Purves and Griesbach (1946) could
reproduce the thyroxine effect in a thyroid cancer and its metastases. When
doses of thyroxine exceeding the daily requirement of the rat were administered,
the thyroid tumours underwent the same involutionary changes which could be
reversed by renewed administration of thiourea. Purves and Griesbach (1947)
noted that under thyroid treatment colloid accumulated only in those benign
or malignant neoplasms which showed a follicular structure.
Paschkis, Cantarow, and Stasney (1948) found in 93.6per cent oftheir animals,
treated with AAF and thiouracil, adenomata and in 14.8 per cent carcinomas of
the thyroid. Of the rats on thiouracil alone 55 per cent developed benign thyroid
tumours and only one neoplasm showed malignant changes. Hall (1948) repeated
Bielschowsky's (1945) experiment giving 6 doses of AAF, a total of 15 mg., to
each rat before methylthiouracil administration was started. Whether the stimu-
lation of the thyroid by the goitrogen commenced immediately after the with-
drawal ofthe carcinogen, or after an interval of4-18 weeks, allpre-treated animals
developed multiple adenomas which appeared earlier than the few single nodules
found in the controls. Hall and Bielschowsky (1949) inquired whether such
small amounts of AAF given prior to methylthiouracil administration played any
role in the malignant change which can occur ultimately in glands after prolonged
stimulation by a goitrogen. In the early stage ofthe experiment more numerous
and larger adenomas were noted in the rats pre-treated with AAF, but all differ-
ences between them and the controls receiving methylthiouracil only disappeared
after 18 months. Morphological signs of malignancy became recognizable in
both groups at about the same time. On the other hand, adenomas induced by
allylthiourea were not transformed into cancers when AAF was given subsequently
to the withdrawal of the goitrogen. Doniach's (1950) findings are in agreement
with Bie]schowsky's (1945) and Hall's (1948) observations. In order to demon-
strate that lack of thyroid hormone was the essential factor in the pathogenesis
of these thyroid tumours Bielschowsky (1949) administered AAF to partially
thyroidectomized rats. In the hyperplastic isthmus of these animals adenomas
developed in the course of 18-37 weeks. Such lesions do not arise in 8 months
in the isthmus of untreated partially thyroidectomized rats.
Thus AAF, even in small amounts, speeds up the development of adenomas of
the thyroid of rats treated with goitrogens. At the same time it increases the
frequency of the nodules. Large amounts of the carcinogen favour the rapid
development of carcinomas.
Money and Rawson (1947) obtained only benign neoplasms of the thyroid by
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the administration ofthiouracil to male rats for periods up to 18 months. Similar
observations were recorded by Laqueur (1949).
In a second communication Money and Rawson (1950) give a detailed, well
illustrated account of the histogenesis of these adenomata. They found no
differences in the morphology ofthe tumours obtained in rats treated with thiour-
acil alone or in combination with dibenzanthracene. In one animal, hemi-
thyroidectomized after 16 months of thiouracil treatment, and kept without
goitrogenforanadditional 9months,thyroidadenomaswerestillrecognizableinthe
remaining lobe which in all other respects had reassumed its normal appearance.
Sellers, Hill and Lee (1953) treated groups of 70 Wistar rats of both sexes for
15 months with propylthiouracil. Of the three experimental groups one received
propylthiouracil alone, the two others the goitrogen supplemented by either
NaI or dried thyroid powder. The body weight of rats receiving the goitrogen
alone or in combination with iodide remained stationary, but the animals provided
with thyroid powder gained weight. The latter had the largest thyroids and those
receiving the iodide supplement the smallest. Neoplastic thyroid lesions devel-
oped in all groups. Four metastasizing tumours were found, one in the propyl-
thiouracil group and two or three in the rats receiving additional thyroid powder.
It is obvious from the iodine content of the thyroid glands at the time of post
mortem as well as from the plasma iodine concentration that the amounts of
thyroxine provided by the dried thyroid powder were insufficient to abolish com-
pletely the thyroid hormone deficiency induced by the goitrogen. This is con-
firmed by the morphology ofthe pituitaries which showed obvious signs ofthyrox-
ine deficiency in all three groups. In this connection some unpublished results
of Hall might be mentioned. He succeeded in suppressing the appearance of
hyper- or neoplastic changes in the thyroids of rats treated with thiouracil by
supplying thyroid hormone in amounts corresponding to the daily requirements,
i.e. 2.5 tg. of d-l thyroxine per 100 g. body weight. The maximal degree of
hyperplasia found by Sellers, Hill and Lee (1953) in rats which received propyl-
thiouracil and thyroid powder is best explained by the state of health of these
animals. In. my experience a high degree of thyroxine deficiency which does
prevent body growth is not necessarily optimal for the induction ofhyperplasia or
neoplasia in the thyroid. Clausen (1953) in a long term experiment with thiourea
found, apart from the usual adenomas, marked degenerative changes combined
with extensive lymphocytic infiltration of the gland, a.picture which bore some
resemblance to struma lymphomatosa.
bis-4-Acetamino-phenyl-selenium dihydroxide seems to be a very potent
goitrogen to judge from a report of Seifter, Ehrich, Hudyma and Mueller (1946).
They fed diets containing 0.05 per cent of this compound to rats and already at
the 105th day of the experiment multiple adenomas were present in the thyroids.
When smaller amounts were fed over periods of 1-2 years the degree ofhyperplasia
observed was rather mild and limited to the interior of the gland; only one ade-
noma was found. Benign liver tumours appeared in these rats, suggestive of a
direct carcinogenic action of the compound (Seifter, Ehrich and Hudyma, 1949).
In the foregoing the terms adenoma and carcinoma have been used. That
we are dealing not with simple nodularhypertrophy but withneoplasms is obvious
from the behaviour ofthe nodules. Theypersist when the stimulus which induced
them is no longer active. Theirmorphology, however, changes when the goitrogen
is withdrawn or when thyroxine is injected in adequate amounts to suppress
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further stimulation by TSH. The epithelium ofbenign as well as ofmetastasizing
tumours tends to assume under these conditions a shape akin to that of a resting
thyroid. At the same time colloid accumulates in these structures as it does in
the non-neoplastic part of the gland. These neoplasms vary considerably in
size and morphology-some are minute structures comprising only a few acini,
others are macroscopically visible nodules considerably larger than the thyroid
of a normal rat. There exist two main types: solid and cystic ones. The solid
micro- or macro-follicular adenomas stand out from the surrounding tissue by
their densely packed cells with hyperchromatic nuclei; they can contain some
colloid when the rest of the gland contains none. In others the cells are arranged
in the form of tubuli and in some the tumour epithelium grows in solid sheets,
divided by strands of connective tissue, and forms acini only occasionally. The
other type is characterized by papillomatous formations growing into cystic,
colloid filled spaces. The degree ofhyperaemia in these adenomas is remarkable,
exceeding that of the rest of the gland. Large, blood-filled sinuses are found
not only inside the nodules, but also often where they border the non-neoplastic
tissue, and only a single layer of,endothelium may separate the tumour tissue
from the large vascular spaces. Regressive changes are not rare. Signs ofrecent
or past haemorrhages are, perhaps, not as common as in human goitres of long
standing. Thus one finds areas where haemosiderin-filled macrophages are lying
in a dense connective tissue. Calcification is rarely seen. The great majority
ofthe benign thyroid tumours have well-defined borders without possessing a true
capsula. Once they have reached a certain size they compress invariably the
surrounding tissue.
Most workers in this field have used the criteria of classical morbid anatomy
for the diagnosis of malignancy: invasion ofneighbouring structures, penetration
of the capsule of the thyroid and metastases, most of which are blood-borne and
therefore located in the lungs; but spread to regional lymph nodes has also been
observed. The incidence of metastases is not related to the structure of the
primary tumour; they occur with well-differentiated as well as with anaplastic
growths. However, both the scirrhous cancers I have seen were invasive.
These morphological criteria of malignancy do not imply that the so-called
carcinomas no longer need TSH for further growth. When transplanted they do
not grow in normal animals, but they take in thyroxine-deficient rats, where they
reach considerable size without killing the animal (Bielschowsky, Griesbach,
Hall, Kennedy and Purves, 1949). When serially transplanted they can change
into highly malignant neoplasms, which may kill normal rats within three weeks
(Purves, Griesbach, Kennedy, 1951). Money and Rawson (1950), however,
succeeded in transplanting into a normal recipient neoplastic tissue obtained
from the thyroid of a rat which had been treated with thiouracil and dibenzan-
thracene. After a lag of 10 months the implant started to grow rapidly and
invaded the surrounding tissue.
2. Thyroid Tumours Induced by Goitrogens in Mice.
At the same time as these investigations were pursued in the rat, workers in
the National Cancer Institute Bethesda and elsewhere attacked the problem in
mice. Dalton, Morris and Dubnik (1945) at first failed to find evidence for neo-
plasia in the hyperplastic thyroids of mice treated with thiourea, but later it
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became obvious that no fundamental difference existed between mice and rats
in their response to goitrogens. In 1948 the same authors gave an account of
the morphological changes seen in the organs of female C3H mice after long-term
ingestion of thiourea and thiouracil. Both compounds induced a remarkable
hyperplasia of the thyroid. After approximately three months pale staining
"parafollicular" cells became increasingly numerous, but obvious neoplastic
lesions were absent. Thyroid tissue which had broken through the gland's
capsule or, in another case, was found between trachealis muscle and the tracheal
epithelium, was considered non-neoplastic and its unusual location due to pressure
and not to invasiveness. After twelve months of thiouracil treatment colloid-
containing follicles increased in numbers and the nuclei of the cells lining them
were smaller and more basophilic. The lungs of approximately 40 per cent of
animals sacrificed after 362-464 days contained nodules ofthyroid-tissue, remark-
ably like the acini of the hyperplastic thyroid gland. When C mice were treated
with thiouracil (Dalton, Morris, Striebich and Dubnik, 1950) for ten or more
months nodular structures appeared in the thyroid. They were of two types,
one formed by large cells with vesicular nuclei and the other by smaller, well
defined elements with more basophilic nuclei. Only one pulmonary metastasis
was seen in this experiment. In view of the poor cytological evidence for a neo-
plastic change, Morris and Green (1951) studied the behaviour of serially trans-
planted "hyperplastic" thyroid tissue. The recipients were mice maintained on a
thiouracil-containing diet. In one line, the original graft coming from a mouse
treated with AAF and the goitrogen, autonomous behaviour, i.e. ability to grow
in a normalhost, appeared in the third generation, anotherline acquired independ-
ence in the ninth. These experiments prove that in the mouse the same sequence
ofchanges occurs as in the rat and that ultimately "autonomous " cancers result.
Morris, Dalton and Green (1951) have given a detailed, beautifully illustrated
account ofthesetransplantationexperiments. Startingfrom a smalladenomatous
area found in the hyperplastic gland of a C3H mouse treated with thiouracil for
18 months, they obtained two tumour lines which differed morphologically and
in their iodine metabolism; but both reached the capacity to grow in normal
hosts after the seventh transfer. One tumour was characterized by a follicular
structure, in the other the cells grew in tortuous cords. Gorbman (1946, 1947)
administered thiourea or thiouracil to mice of several inbred strains and to some
hybrids. He found nodular structures in the thyroid after treatment for 220-300
days; they developed from the ingrowth of tiny follicles or cellular cords into
colloid cysts which were most prominent during the 180-200th day of the experi-
ment. Thyroid tissue noted inside blood vessels and in the lungs was considered
to be metastatic but not neoplastic. It is ofinterest that, in contrast to what has
been observed in the rat, all these lesions disappeared rapidly after the withdrawal
of the goitrogen and that neither AAF nor benzpyrene did enhance the action of
the goitrogen.
3. Thyroid Tumours Induced by Radio-iodine in Rats.
In a series of papers Goldberg and Chaikoff and their associates have given a
description of the changes in the rat's thyroid which follow treatment with radio-
active iodine. Goldberg, Chaikoff, Lindsay and Feller (1950) tested four dose-
levels of 1131, namely 18, 300, 525 and 875 microcuries. The injected animals
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were sacrificed after intervals ranging from 6 hours to 8 months. Only the long-
term effects will be discussed, the two lower doses did not induce permanent
changes. With the largest dose thyroid destruction was nearly complete and
only in one animal glandular epithelium could be recognized 8 months later.
With 525 Ic. recovery from radiation damage took place to a certain extent and
at the end of the experiment the thyroids of two animals were hyperplastic and
resembled those after prolonged thiouracil treatment. Cells with ample eosino-
philic cytoplasm and large irregular nuclei, likened to the so-called Huiirthle cells
of human pathology, were noted, the only atypical type of thyroid cells seen in
this investigation. Money et al. (1953) found also " Hiirthle cells "in the thyroids
of rats treated with methylthiouracil, evidence that they owe their existence
not necessarily to irradiation but probably to continued stimulation of the thyroid.
That the presence of bizarre cells in irradiated thyroids is not interconnected with
adenoma formation is evident from the findings of Maloof, Dobyns and Vickery
(1952). They discovered only one adenoma in 500 rats treated with 1131 although
gross cytological abnormalities were noted in many. In a second study Goldberg
and Chaikoff (1951) administered doses of 400 ,tc. of 1131 and extended the period
of observation to 18 months. They found in the thyroids of 2 rats multiple
adenomas. Most were sharply defined, but two of the nodules blended with the
surrounding tissue, were more cellular and richer in mitoses, and therefore suspect
ofbeginning malignancy. In 1952 the same authors described the thyroid cancers
present in rats treated with 400 ,tc. of 1131 and sacrificed 18-24 months later.
Nine of 25 animals had neoplastic lesions in the thyroid. Seven of these tumours
were considered malignant because five had metastasized and the other two had
invaded adjacent tissue and blood vessels. In the strain of rats used by Goldberg
and Chaikoff propylthiouracil failed to induce thyroid cancers, although 24 of 125
animals developed benign adenomas.
Doniach (1950) studied the effect of radio-iodine alone or in combination with
methylthiouracil and/or AAF upon the thyroid. He worked with rats of the
Lister strain, a colony in which single adenomas of the thyroid occur in 25 per
cent of the animals at the age of 13 or more months. Two injections of 16 ,ac.
each were given 5- months apart and the rats sacrificed 12-151 months after the
administration of the first dose. Their thyroid glands were smaller than normally,
but the majority contained two or more follicular adenomas. When the J131
treatment was followed by administration of methylthiouracil multiple thyroid
turnours developed and in one animal most of the tissue of the gland was replaced
by adenomas, one of which had metastasized to one of the adrenals. The control
group treated with methylthiouracil alone had large hyperplastic thyroids con-
taining up to three benign neoplasms. The number of animals having tumours
in their thyroids was the same in the two groups treated with radio-iodine or with
methylthiouracil. Exposure to 1131 followed by goitrogenic stimulation led to
the formation of neoplasms which were larger and more frequent than those
induced by either agent, and on one occasion to malignant changes. Rats treated
with AAF alone had normal or slightly stimulated glands and in 50 per cent of
them 1-3 adenomas were present. Additional treatment with radioactive iodine
did not increase tumour incidence in the thyroid. However, the simultaneous
administration of the carcinogen and of methylthiouracil led to the formation of
large nodular goitres and in two rats to an adenomatous replacement of most of
the gland. The majority of the animals injected with I131 and receiving in their
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drinking water AAF and methylthiouracil had moderately enlarged thyroids.
In all of them adenomas were extremely numerous and one of these thyroid
tumours had become malignant.
There is a striking parallelism between the results obtained in rats treated with
I13l1 and methylthiouracil and those obtained by the simultaneous administration
ofAAF and the goitrogen in so far as prolonged stimulation intensifies the carcino-
genic effect of both I131 and AAF.
In a more recent publication Doniach (1953) recorded the results of a second
experiment in which the action of 30 /#c. of 1131 alone or in combination with
methylthiouracil was investigated and compared with the effects obtained with
5 uc. and 100 /tc. respectively. The duration of the experiment was 15 months
and the age of the rats at start 10 weeks. Of the three dose levels of 1131 tested
5 ,uc. and 30 pc. seemedequally effective as far as tumour formation was concerned.
Both induced thyroid adenomas in 50 per cent of the injected animals, whereas
the glands ofthe rats treated with 100 ,uc. did not contain neoplastic lesions. Still
more impressive were the differences in the thyroids exposed to 5, 30 or 100 uc.
when the glands were subsequently subjected to goitrogenic stimulation. All
rats pretreated with 5 ,uc. had multiple benign adenomas of a size never reached
by the neoplasms found in the thyroids of animals treated with methylthiouracil
alone. In rats injected with 30 ,c. and treated with the goitrogen afterwards
the thyroid tumours were still larger and 5 of them obviously malignant. The
thyroids of rats injected with 100 ,uc. failed to respond to goitrogenic stimulation
and relatively few adenomas of moderate size developed.
The work of Doniach and of Goldberg and Chaikoff has established that
amounts of 1131 which damage the thyroids but still allow them to respond to
stimulation by TSH can be expected to induce neoplastic lesions in this organ.
The tumours observed under these experimental conditions did not differ essen-
tially from those seen after prolonged administration of goitrogens despite the
presence of many bizarre elements in the irradiated glands. The accompanying
changes in the pituitaries have been well described by Goldberg and Chaikoff
(1950) and by Doniach (1953), and have been interpreted as being due to impaired
thyroid function.
4. Thryoid Tumours Induced by Radio-iodine in Mice.
Gorbman (1949) using a wide range of doses of radio-iodine failed to detect
any neoplastic changes in thyroids of mice injected at the age of 6-9 weeks.
Speert, Quimby and Werner (1951) injected 200 Pc. of 1131 into pregnant mice
during the last three days of gestation and studied its effect on the offspring.
There was evidence of thyroid damage early in life, but when the animals were
5 months old the glands had recovered and took up 1131 in normal quantities.
Four to seven months later the thyroids were found to have a fibrotic centre,
and to contain hyperplastic nodules with areas showing papillary ingrowth into
follicles as well as colloid-filled cysts lined by a fiat epithelium. Rugh (1951a)
established that a major proportion of radio-iodine injected into a nursing mouse
is excreted with the milk and therefore affects the suckling offspring. In a second
communication (195lb) he described the changes which occur in the thyroids of
mice nursed by mothers which had been injected on the 3rd day of lactation with
doses of 3-20 uc. of 1131 per g. body weight. No tumours were foundin the thyroid
of the offspring 10 months later.
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5. Thyroid Tumours Due to Iodine Deficiency.
The occurrence ofnodular goitres in rat colonies kept in localities where goitre
is endemic was first noted in Switzerland by Langhans and Wegelin (1919), and
Wegelin (1927) recorded later the presence of malignant lesions in such enlarged
thyroids. A similar observation was recently made in New Zealand, another
country with endemic goitre. In spring 1951 enlarged, hyperaemic thyroids
were seen in a fair number of experimental and of untreated rats of our colony,
a phenomenon not observed by the writer in a large number of autopsies carried
our during the previous three years. The fact that all cases of "spontaneous"
thyroid enlargment were found at the same time and the disappearance of these
goitres after providing the animals with additional iodide in the drinking water
suggested iodine deficiency as the aetiological factor (Bielschowsky, 1953). Only
the tumours found in untreated rats will be considered. Although the tumours
seen during the active phase of the disease were of fair size, only one was recog-
nizable at naked-eye inspection. Some were macrofollicular, others tubular and
some were undifferentiated. All but one were well-defined benign neoplasms, the
exception being one of the less differentiated, solid tumours which seemed to
invade the surrounding hyperplastic thyroid tissue. The neoplastic lesions dis-
covered in the resting glands oftwo aged animals 3-7 months after supplementary
iodide had been provided, were rich in colloid and resembled closely the cyst
adenomas seen in thyroids ofrats after cessation ofgoitrogen treatment. Axelrad
and Leblond (1953) studied the induction of thyroid tumours in rats fed a low
iodine diet alone or with the addition of AAF. After one year a high percentage
of animals in both groups were found to have thyroid tumours, some of which
showed histological evidence of malignancy. These observations are in line with
those of Hellwig (1935), one of the earliest workers to obtain thyroid tumours by
means of an iodine deficient diet.
6. Thyroid Tumours in Intrasplenic Grafts.
According to some European and South American workers intrasplenic trans-
plantation of thyroid tissue after complete removal of the gland from the trachea
leads to a hyperplasia of the graft (Gabe and Arvy, 1947). Brachetto-Brian and
Grinberg (1951) as well as Lacour, Oberling and Guerin (1951) observed nodular
hyperplasia in intrasplenic thyroid grafts 14-15 months after the operation, and
Cordier, Craps and Martin (1951) recorded the appearance of one trabecular
adenoma, the only observation of this kind. Neither Bondy (1951) nor Rupp
(1952) found evidence for thyroid hormone deficiency in rats bearing thyroid
grafts intheir spleen, nor did they find histologicalsigns ofincreased activityin the
transplanted thyroid epithelium. Thus the Biskind technique, so successful in
the case of ovary and testis, hardly ever leads to the development of thyroid
tumours, a result to be expected because this method more often than not fails to
induce a thyroid hormone deficiency. However, Pasqualini and Mancini (1951)
discovered in the pituitary of rats bearing thyroid grafts in the spleen changes
characteristic of partial thyroidectomy.
7. Functional Activity of Thyroid Tumours.
Doniach (1950) was the first to obtain evidence of functional activity in an
experimental thyroid tumour. He found that 12 days after cessation oftreatment
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with AAF and methylthiouracil a follicular adenoma took up I131, although to a
lesser extent than the surrounding tissue. Purves, Griesbach and Kennedy (1951)
worked with a transplantable thyroid tumour growing in rats which received 0.01
per cent methylthiouracil in the drinking water. They found that the graft
could concentrate1131 and assimilate it into organic form, despite the presence of
the goitrogen. From the study ofthe pituitaries ofthyroidectomized rats bearing
such transplants the conclusion was drawn that the graft secreted thyroid hormone.
Well granulated acidophils, absent from the pituitary of rats lacking TH, re-
appeared in the adenohypophysis and became rather numerous; the counts of
basophilic cells gave values below those characteristic for complete thyroidectomy.
These results are representative for transplanted tumours which can grow only
in thyroxine deficient animals. An anaplastic thyroid tumour which could be
propagated in normal rats was not functionally active. Wollman, Morris and
Green (1951) published data on the 1131 uptake of four different lines of trans-
plantable thyroid tumours and of the thyroid glands of their hosts. One of the
grafts took up very small and two moderate amounts, but the fourth was function-
ally so active that it depressed the norma] activity of the host's thyroid. This
transplant incorporated more 1131 into thyroxin than the thyroid of the tumour-
bearing mouse. Wollman, Scow and Morris (1953) furnished additional data on
the iodine metabolism of 6 tumour lines three ofwhich depended still on continued
thyrotrophic stimulation for their growth. They found that the grafts of the
three dependent tumours could perform both functions of the normal thyroid
to various extents; they could concentrate113l and bind it in organic form. Even
in the functional most active tumour graft the latter function was more impaired
than the former. Of the three independent lines one had lost all functional
activity, but the other two could still incorporate iodide into organic binding.
Attempts to alter the iodine metabolism of one independent tumour by treating
the host with goitrogens failed. In contrast to what has been seen in some human
cancers or in experimental tumours of the rat, the incorporation of I131 into an
organic molecule was nearly completely blocked by propylthiouracil and the
capacity of the tumour to concentrate iodine remained unchanged. Of great
interest are the investigations of Money, Fitzgerald, Godwin and Rawson (1953),
who studied 1131 uptake by the thyroids of rats kept for up to 700 days on a
thiouracil containing diet. Twenty-four hours before autopsy the animals were
injected intraperitoneally with 5pc. of1131. Radio-autographs ofparaffin sections
of the adenomatous goitres revealed the presence of areas rich in I131. Usually
in rats treated with a goitrogen the hyperplastic thyroid tissue takes up less iodine
than normal thyroid tissue, and most of it is found in the inorganic fraction.
The fact that the I131 was not lost during the preparation of the sections suggested
that iodine had been incorporated into an organic molecule. It was located
in atypical follicles and in adenomas, whereas the non-neoplastic tissue seemed
free ofradio-activity. Thus a new type ofcell had apparently come into existence
which could accumulate and bind in organic form I131 in the presence ofthiouracil.
Three possibilities exist: either the new tissue was no longer affected by concen-
trations of goitrogen which blocked thyroxine synthesis in non-neoplastic follicles
or it had acquired the ability to incorporate iodine into organic molecules by new
pathways. In this case the end-product of the synthetic process would probably
be different from that formed normally. The third possibility would be a reduced
ability of the neoplastic tissue to concentrate the goitrogen, whereas the hyper-
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plastic follicles still performed this function. As shown by Schulman and Keating
(1950) and by Schulman (1950) the thyroid can achieve a thirtyfold concentration
of thiourea.
The work on the iodine metabolism of experimental thyroid tumours and their
grafts has furnished results which are in good agreement with those obtained in
human cancers of the thyroid. Rawson, Skanse, Marinelli and Fluharty (1949)
noted that thiouracil interfered less with the uptake of iodine by functional carci-
nomas than by normal thyroid tissue. In man as in rodents the well differentiated
tumours are prone to concentrate the isotope (Dobyns and Lennon, 1948; Fitz-
gerald and Foote, 1949). In most instances the amounts trapped are far below
those taken up by the normal thyroid. However, occasionally considerable
quantities may be retained, as for instance by the rare thyroid cancers which
produce signs of hyperthyroidism (Seidlin, Marinelli and Oshry, 1946).
Many non-functional metastasizing tumours will take up radio-iodine after
total thyroidectomy or in response to injections of TSH or to the administration
of a goitrogen. After surgical removal ofthe thyroid Rall, Miller, Foster, Peacock
and Rawson (1951) noted an increased uptake by the metastases in 21 of 30
patients under the influence of thiouracil. Of great theoretical interest is their
observation that some of these tumours acquired rather abruptly the capacity
ofcollecting1131, whereas others did so only gradually. Since a follicular structure
seems to be the pre-requisite for the trapping of iodine these observations imply
a change of the neoplasm towards differentiation.
8. Pituitary Tumours.
Enlarged or obviously neoplastic pituitaries have been observed by many
workers studying the effects of long continued TH deficiency in rats or mice. It
took rather a long time to establish the significance of these lesions because several
obstacles mnilitated against their proper assessment. In the rat they occur most
frequently at an age when "spontaneous" pituitary tumours make their appear-
ance. In addition they may even have some resemblance to the "spontaneous"
tumours. Better understanding of the normal histology of the rat's pituitary and
the introduction ofnew staining techniques have helped to trace their development
from the TSH producing basophils of the adenohypophysis. The best evidence,
however, comes from the study of the pituitary tumours which can be readily
induced in several strains of mice by T131 given in thyroid destroying amounts.
They were discovered by Gorbman, and Furth and his associates established
their nature. Gorbman (1949) found that doses of 80-300 Itc. of radio-iodine led
to a progressive enlargment of the pituitaries, well recognizable already 150
days after the injection. Large tumours were present 100 or more days later,
their size being related to the dose given, the largest tumours appearing in the
group treated with 300 ,c. Mice kept on a thiouracil containing diet for 400 days
had enlarged pituitaries, but no neoplasms in the adenohypophysis. Whereas
200 uc. I131 were needed for near complete destruction of thyroids of mice on a
well balanced diet, 30 Itc. achieved nearly the same effect in animals previously
fed a low iodine ration; but such mice did not develop pituitary tumours (Gorb-
man, 1951). Since implantation of thyroid tissue and to a lesser degree adminis-
tration of thyroxine prevented pituitary enlargement as well as tumour formation
in mice receiving effective amounts ofI131, Gorbman (1952) came to the conclusion
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that ionizing radiations in combination with TH deficiency were the
essential
factors for the development of these neoplasms. The failure of small but thyroid-
destroying doses of 1131 to induce neoplastic growth in the pituitary was confirmed
by Gorbman and Edelman (1952). The combination of whole body irradiation
(545 r) and ofradio-thyroidectomy by 30 ,uc. 1131 was found to be effective,
whereas
each agent alone was not carcinogenic for the pituitary. It might be pointed out
that the tumours of the adenohypophysis developing after exposure to 1131 are
not the only type which can be induced in the pituitary by radiations.
Another
entirely different type, has been found by Furth and his collaborators (Furth,
Gadsden and Upton, 1953; Upton and Furth, 1953), in mice exposed
to atomic
detonations. Gorbman's results amplify observations of Goldberg and Chaikoff
(1951). Having failed to induce pituitary tumours in rats with amounts 1313
up to 875 ,uc., they treated mice with 600 ,uc. Only marked hyperplasia
of
basophilic cells in the anterior lobe resulted; these cells appeared hypertrophic
and showed increased mitotic activity. A supplement of desiccated
thyroid
prevented these changes.
From the experiments of Speert et al (1951) and of Rugh (1951) in which mice
wereexposed to I131 three days prior to or after birth it is evident that total thyroid
destruction is not essential for the subsequent development of pituitary tumours.
These workers noted a considerable degree of anatomical and functional
recovery
of the thyroids, and although these glands were far from normal they
must have
secreted some TH to judge from the near normal weight reached by these mice.
Nevertheless, a considerable number of them developed pituitary tumours 10-12
months after exposure to 1131. Recently Silberberg and Silberberg (1953) pub-
lished data on the influence ofgenetic factors and on the enhancing effect
of
a
fat diet on the development of radio-iodine induced pituitary tumours.
Furth and Burnett(1951) transplanted pituitary tumours which haddeveloped
in mice treated with I131 and found that these implants would not grow in normal
mice, but in animals subjected previously to radio-thyroidectomy.
Later Furth,
Gadsden and Burnett (1952) obtained by serial transplantation tumour lines the
growth of which was not any more dependent on the absence of TH.
These
autonomous grafts grew more rapidly than the dependent transplants, metasta-
sized into lymph nodes and, what was most important, the presence
of an intact
thyroid in the host allowed the recognition of their secretory activity.
Grafts of
microscopic size already stimulated the thyroid of the host. When they enlarged
they induced nodular goitres in due course. Assays of the hormone content
(Furth, Burnett and Gadsden 1953), performed in Furth's own and three
other
laboratories, confirmed the high TSH content of the transplanted
pituitary
neoplasms. Of special interest were the assays of Evelyn Anderson, which
cated that no other hormones were present in significant amounts.
Additional
evidence for the TSH secretion of the transplants was furnished by the study
of
the iodine metabolism ofgrafted animals in which a marked tendency for iodine
retention was noted.
The presence of pituitary tumours in mice (Moore, Brackney and Bock, 1953)
and in rats treated with goitrogens for prolonged periods has been frequently
observed (Griesbach, Kennedy and Purves, 1945; Seifter, Ehrich and Hudyma,
1949; Sellers etal., 1953; Purves and Griesbach, 1951) and by Doniach (1953)
two
rats treated with 100 Itc. 1131. Only in the two last-mentioned publications
these
tumours are referred to as basophil adenomas, whereas most other authors
classify
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them as chromophobic. Recently the writer (1953) described the occurrence of
basophil adenomas in conjunction with nodular goitres in rats suffering from
chronic iodine deficiency. A similar observation was recorded by Fischer (1926)
who found in two aged rats neoplasms in thyroid as well as in pituitary. Her
animals came from Wegelin's colony, in which goitre was endemic. The cells
forming these basophil adenomas resembled strongly normal thyrotrophs in
appearance and in their staining qualities. These cytological findings together
with the fact that of all pituitary dependent organs only the thyroid was stimu-
lated, was considered evidence of their TSH secreting activity. Since this hor-
mone is formed by a special type of basophil, the thyrotroph of Purves and
Griesbach (1951a, 1951b), these neoplasms were classified as basophilic adenomas,
although in some "basophilia" was not a prominent feature. Apparently as
long as the animals are deficient in TH these tumours do not store TSH, and only
a few of their cells stain basophilic or with the PAS or Gomori's fuchsine-aldehyde
reagent, a behaviour similar to that of the non-neoplastic thyrotrophs. Therefore
it is debatable whether the name basophil adenoma is the most appropriate, the
term TSH-secreting adenoma would be more precise. To call them chromo-
phobic adenomas isnmisleading. A degranulated thyrotroph or,8 cell to use
Romeis's (1940) classification ought to be distinguished from a chromophobe or
y cell.
To summarize: Thyroid hormone deficiency is the one factor common to all
observations reviewed in this section. Whether this deficiency is due to an in-
sufficient iodine content ofthe diet, or is induced bygoitrogens through interference
with the enzymatic mechanism by which the thyroid synthesizes TH, or to damage
or destruction of the gland by ionizing radiations, the result is always the same.
The pituitary reacts to the lowered thyroxine level with an increase of those
basophils which secrete TSH, a process akin to compensatory hypertrophy. In
the rat it takes a long time before this process leads to irreversible changes in the
adeno-hypophysis and a tumour results. In the mouse radio-iodine, perhaps by
a direct radiation effect on the pituitary, speeds up adenoma formation. The
thyroid reacts to thyrotrophic stimulation with hyperplasia, which is first diffuse,
then becomes nodular and finally neoplastic lesions appear which can show the
morphological signs of malignancy. This sequence of events can be more easily
demonstrated in the rat than in the mouse. When the life of the experimental
thyroid tumours and the period of stimulation are prolonged by serial transplanta-
tion, carcinomas result whichgrow in normal animals, i.e. they become independent
of the stimulus responsible for their initiation and development. The same phen-
omenon has been observed with the TSH secreting tumnours of the mouse pituitary.
Tumourigenesis in the rat's thyroid can be speeded up by chemical carcinogens
and by ionizing radiations. As Doniach (1953) has pointed out, the danger of
tumour development is greatest at a certain dose level, namely with amounts of
1131 which do not abolish the ability of the gland to react to TSH. Of importance
is that all the neoplastic lesions, be it in pituitary or thyroid, can be prevented by
supplying the animals with adequate amounts of TH.
9. Cancers of the Human Thyroid.
It is outside the scope of this contribution to review the vast literature on
neoplastic lesions of the human thyroid. The conception of hyperplasia as first
step to tumour formation in this organ seems to be generally accepted. Taylor
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(1953) tracing the evolution of nodular goitre writes: "This series begins with a
simple diffuse enlargement of the gland in a young patient and ends with the large
multinodular goitre showing evidence of haemorrhage and calcification in the
older individual ". Admittedly regression in human nodular goitre is a more
frequent event than in the rat, and such regressions occur perhaps more often at
a time when the process is still reversible, i.e. in the stage of nodular hyperplasia.
Nevertheless, a certain number of nodules arising in hyperplastic glands become
neoplastic and sometimes malignant. Wegelin (1928) states: "Where goitre
is endemic, malignant tumours of the thyroid occur in greater numbers ". Statis-
tical data (Wynder, 1952) show a remarkable decline in the death-rate from cancer
of the thyroid since the introduction of iodized salt into the canton of Zurich in
1923, evidence for the etiological significance of iodine and in consequence
thyroid hormone deficiency in the causation of cancers of the thyroid. Ivy (1947)
found in 2000 autopsies of adult dogs in Chicago an incidence of 89 per cent of
goitres and of 1.6 per cent of metastasizing thyroid tumours before 1925. Two
years later, after the introduction of iodized salt, both lesions had disappeared.
Thus there exists agratifyingagreement betweenexperimental andclinical findings.
Still more satisfactory is that the type of thyroid cancer associated with endemic
goitre seems preventable by a correction of the hormonal imbalance. However,
as far as the human pituitary is concerned, there is hardly any evidence for tumour
formation as a sequence to chronic thyroid hormone deficiency. From the fore-
going it should not be assumed that the problem of thyroid cancer is a closed
chapter. Especially, thyroid cancer in children and adolescents poses unsolved
problems. Duffy and Fitzgerald (1950) found in the histories of 28 juvenile
patients 10 in which the thymus had been irradiated between the 4th and 16th
month of life. Whereas it is understandable why these neoplasms became mani-
fest at the time of puberty, a period of increased growth rate of the gland, the
etiological relationship between irradiation of the thymus and neoplasia in the
thyroid is obscure. In a similar series of Warren, Alvizouri and Colcock (1953)
neither irradiation of the thymus nor iodine deficiency played a significant etio-
logical role. There is another type of carcinoma of the thyroid in which a history
ofprevious goitre is frequently missing: the highly malignant anaplastic tumours
found in elderly patients (Crile, 1953).
The question how often malignant changes occur in human nodular goitre
has been answered differently and has been ably discussed by Cope (1952). Some
surgeons are convinced of the great potential danger inherent in multinodular
goitres and still more in the so-called solitary adenomas (Cole, Slaughter and
Rossiter, 1945; Lahey, Hare and Salzman, 1950; Lahey and Hare, 1951). How
erroneous the clinical impression of a solitary nodule can be has been pointed out
by Hermanson, Gargill and Lesses (1952), who found nearly as many malignant
lesions in multi- as in uninodular goitres. In any case statistics based on surgical
material have not been substantiated by post mortem findings. Hazard and
Kaufman (1952) found in 408 consecutive autopsies of adults in a so-called goitre
area (Cleveland) 213 normal glands and 195 containing one or more nodules. In
the goitrous glands they discovered one papillary adenoma, two papillary car-
cinomas and one non-encapsulated sclerozing tumour, none ofwhich had produced
clinical symptoms. It seems therefore that progress to malignancy is as rare an
event in human nodular goitre as in that of the rat. When it happens it does not
constitute necessarily a danger to life. Survival times of decades in untreated
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cases ofpapillarycarcinoma are not exceptional even when the first symptoms were
enlarged lymph nodes sign of regional metastasis.
10. Experimental Thyroid Tumours, an Example of Responsive Tumours.
Whether the experimental thyroid tumours of the rat pass through a stage
where they can regress completely is not known, but most of them remain depen-
dent on hormonal stimulation during the lifetime of the host. Even when they
have become cancerous and have spread to distant sites, they can still respond to
variations in theblood level of TSH. Foulds (1951) distinguishes two types of
tumours, responsive and non-responsive. Few pathologists or clinicians will offer
serious objections to Fould's scheme of progression of tumours, the end-point
of which is the unresponsive state. The writer is in complete agreement with the
statement that "progression may be halted at any stage and does not always
reach its end-point within the lifetime of the host". It should, however, not be
forgotten that serial transplantation by means of which an experimental tumour
might reach the final stage gives the latter the advantage of immortality. In
the case of the thyroid tumours two hormones, TSH and TH decide the issue.
Such a clearly discernible situation is unfortunately rare. There exist neoplasms
where the problem is far more complicated and where two questions have to be
asked: are they responsive? and: to what do they respond ? The literature of
the last years contains examples of cancers of the breastreacting first favourably
to ovariectomy. Then they recur to regress perhaps under the influence of testo-
sterone. They resume growth after a while to be arrested by adrenalectomy or
hypophysectomy. Before attempts were made to control carcinomas of the
breast by these means one would have considered all widely metastasizing cancers
to have reached the end-point. That may have been true for many, but certainly
not for all. These remarks do not imply any criticism of Foulds' scheme and of
the concept ofprogression as an intrinsic property of the tumour cell. They are
intended to point out how difficult it can be to be sure that the end-point has been
reached.
In a recent review Furth (1953) referring to the experimental tumours of
thyroid and pituitary writes: "Most current theories regard the basic alterations
in cancer as residing not in the host but in the neoplastic cell", and continues
"in this review tumours will be surveyed which find their origin in alteration of
the host". Cancers of known etiology like, for instance, those induced by a
chemical agent, such as benzpyrene, are growth-responses of a susceptible tissue
to a chemical carcinogen. In the writer's opinion such neoplasms do not differ
fundamentally from those resulting from continued stimulation by the secretions
of an endocrine gland. What differs is the origin of the agents and perhaps their
potency. Whether one studies the histogenesis ofchemically-induced skin tumours
or ofexperimental thyroid tumours, one sees the same sequence of events: first
diffuse hyperplasia, followed by nodular hyperplasia and finally by frankly neo-
plastic growth. This in itself is highly suggestive for the similarity of the process
induced by entirely different agents in two different organs.
As far as the granulosa and lutein cell tumours of the ovary of rodents are
concerned, they can be obtained by various means: by gonadotrophic stimulation
alone (Biskind and Biskind, 1944; Lipschutz, Ponce de Leon, Woywood and Gay,
1946), by the combination of an exogenous carcinogenic agent and hormonal
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stimulation (Bielschowsky and Hall, 1951) and, possibly, by a carcinogen alone
(Marchant, Orr and Woodhouse, 1954). Even should it be proved that the granu-
losa cell tumours induced by 9:10 dimethyl-1: 2-benzanthracene need for their
development an elevated gonadotrophin level, there would only be a quantitative
difference between them and, for instance, a methylcholanthrene-induced sarcoma.
In the latter case normal amounts ofpituitary secretions allow a neoplastic growth
response to the carcinogen, but these sarcomas do not develop in the hypophy-
sectomized rat (Moon et al., 1952). Thus for the development ofsome chemically-
induced neoplasms normal amounts of pituitary secretions are sufficient, some
need more, and for tumourigenesis in the skin they do not appear to be necessary
at all. On the other hand a fair number of neoplasms can be obtained by hor-
monal stimulation alone. It seems arbitrary to divide neoplasms into two cate-
gories-those induced by exogenous and other sinduced by endogenous agents.
It has been argued that the experimental thyroid, pituitary and ovarian tumours
differfromchemically-induced cancersbecausetheydependforsolongon continued
stimulation. However, the same is the case with many neoplasms due to exo-
genous agents, such as the tar tumours of the rabbit's ear and the neurofibromas
which appear in rats after feeding of ergot-containing diets (Nelson, Fitzhugh,
Morris and Calvery, 1942). I see, therefore, no fundamental difference between
a neoplastic growth response to a hormone and one to an exogenous carcinogen.
It has been pointed out before that certain thyroid tumours which were
anaplastic and non-functional can become functionally active under the influence
ofthyrotrophic hormone. A similar observation was reported by Hooker, Pfeiffer
and Strong (1947); Hooker (1948). A malignant non-functional interstitial cell
tumour of a mouse changed under the influence of equine gonadotrophin to an
androgene-secreting neoplasm, and although the tumourgrewrapidly the primitive
Leydig cells assumed the appearance of mature Leydig cells. Thus in responsive
tumours growth and differentiation need not oppose each other.
IV. THE RETROGRESSION OF TUMOURS.
On February 27, 1900, Pearce Gould, of the Middlesex Hospital, London,
demonstrated patients suffering from cancer of the breast showing signs of focal
or systemic retrogression. He wanted to call attention to one point: "the fact
of repair in cancer ". "A recognition of this fact will not affect our views of the
true nature of cancer, but it will act as a constant stimulus to us to find out some
method of treatment, some therapeutic agent, for this disease which will lead to
this repair."
Some aspects of retrogression of tumours with special emphasis on the mor-
phology of hormone-induced regression will be discussed in the last part of this
contribution.
1. Spontaneous Regressions.
It is not my intention to review all recently recorded cases of spontaneous
retrogression of cancer in man. Three well documented examples ought to suffice
to convince the sceptic ofthe reality ofthe phenomenon.
Dunphy (1950) recorded a case of a post-menopausal woman, 54 years of age,
with a tumour in the lower abdomen. Laparotomy revealed the presence of
multiple tumour nodules in the omentum and ofa mass which had involved uterus
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and adnexae and was adherent to loops of small intestine. The tumour was
considered inoperable and the abdomen was closed after a biopsy had been taken.
The histological diagnosis was small-cell carcinoma. After two years the patient
had improved. Eight and a half years after the operation a mass appeared in
the right groin which grew slowly for one year when the patient re-entered the
hospital. The original tumour in the pelvis had disappeared and the uterus
seemed to be normal; roentgenograms of the lung were highly suggestive for
miliary metastases. The mass in the groin, encapsulated lymph nodes, were sur-
gically removed and found to be full of malignant growth of a structure similar
to that of the biopsy. Two years later-in the interval the patient had become a
diabetic-asmalllumpwaspresentontherightsideoftheneckwhichhaddeveloped
during the precedingtwelvemonths. This wasfoundtobe abenignlipoma. Thus
thirteen years after an inoperable carcinoma had been found and four years after
removal of metastatic lymph nodes the patient was alive and without signs of
malignant disease. Sumner (1953) described a case of spontaneous regression ofa
malignant melanoma in a young woman. Three and a half years before the
patient sought medical advice a black mole above the internal malleolus of the
left leg had become infected and disappeared. During a following pregnancy a
lump appeared in the left groin which was not treated. Three years later, when
the patient was again pregnant for six months, nodules were present in the right
breast, in the left arm near the shoulder, and several smaller ones in the sub-
cutaneous tissue of the abdominal wall and the back. On operation the tumours
of the right breast, left arm and left femoral region were found to be partly solid,
partly cystic, deeply pigmented structures. The histological diagnosis was malig-
nant metastasizing melanoma. Although the prognosis appeared hopeless, an
attempt was made to remove the subcutaneous nodules also. Astonishingly
enough, all the incisions healed although the tumours were torn during the opera-
tion. Two months later the patient delivered a normal child. Eight months
post-partum she returned with a recurrence in the femoral region which was
excised, as was another found in the right supraclavicular region seven months
later. From then on no further metastases appeared and the patient seemed free
of neoplastic disease four years after the first operation. Apparently this not
very malignant melanoma of the left leg had produced metastases to the groin
during the first pregnancy; then the process became stationary until, during the
next pregnancy, multiple secondaries developed. Since the surgeon disclaims
complete removal of all malignant tissue the melanoma which progressed twice
during pregnancy must have undergone systemic retrogression. The third
example is a case of sarcoma in a male baby (Penner, 1953). The tumour, dis-
covered when the child was two months old, measured 5 cm. and had produced a
defect in the left femur. The histological diagnosis of a biopsy specimen, con-
firmed by F. W. Stewart and F. W. Foote, was sarcoma. No treatment was given.
When the child was traced five years later there was no evidence of neoplastic
disease and the mother stated that at the age of nine months the tumour had
disappeared. Ofinterest is that at the time the sarcoma ofthe leg was discovered
a swelling was also present in the left sterno-mastoid muscle. When the child
was re-examined at the age offive and a halfyears this area was atrophic.
These observations illustrate that retrogression of cancers with an extremely
bad prognosis can occur at any time of life. There is no hint as to the factors
responsible in two of them. Only in the case of the melanoma the clinical course
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suggests a hormonal influence. Whereas such cases are extremely rare departures
from the usual course of malignant disease, there exist uncommon neoplastic
lesions, such as papillomatosis of the larynx in children in which retrogression is
the rule. Although generally of a self-limited character, regressing at the time of
puberty, the condition has a high rate of recurrence and is potentially malignant.
Walsh and Beamer (1950) have described two children in which the disease pro-
gressed to epidermoid carcinoma, and mention a third case. In contrast to the
papillomas of the adult which are more often than not single, in children they are
multiple and can spread into the trachea. Why, as reported by Cunning (1950),
the papillomatosis of the upper respiratory tract in children has become increas-
ingly rare is unknown. Attempts to bring on puberty by injection of testosterone
failed to affect the papillomatosis in one case, but Broyles (1940) reports five
remarkable regressions in children of both sexes under local treatment with
oestrogen. Zalin (1948) had two successes with this therapy, whereas Gorrell
(1952) was unable to influence the growth. That endocrine factors can influence
the course ofpapillomatosis is clearly demonstrated by a case recorded by Holinger,
Johnston and Anison (1950). The patient, a young woman, had undergone
sixty-three endoscopic procedures for removal of recurrent laryngeal papillomas
in thirteen years. Over this period she had three pregnancies and during each
the papillomas disappeared to recur with the onset of menstruation. Whatever
the etiology of the condition, there can be no doubt that hormonal factors have
some influence on the regression or progression of papillomatosis of the larynx.
In a way this condition shows an opposite trend to that of juvenile melanoma
it has greater growth potentialities prior to puberty. Facts like these should
make one beware of generalizations. The question whether tumours are more
malignant in the young than in the old cannot be answered, not even when cancers
of the same organ are considered. For instance, inflammatory cancer of the
breast is an extremely rare condition in women beyond the age of sixty, but when
it occurs in the male patient it is found in the seventh or eight decade oflife (Treves,
1953)..
2. Mllorphology of RegreTssion.
Retrogressions induced by hormonal treatment have become an accepted
fact (Nathanson, 1951, 1952). Studying the literature dealing with this pheno-
menon one is impressed by the paucity of adequate descriptions of the morpho-
logical changes occurring in tumours regressing under the influence of hormones.
An attempt has been made to collect the existent data in the hope that others
might feel inclined to fill the obvious gaps. The writer feels that in this way worth-
while information could be gained which might help in our understanding of the
action of hormones on malignant growth. Based on nearly a hundred years of
practical experience pathologists have learned to recognize the morphological
signs which are the mark of cancer. When a tumour has invaded neighbouring
tissue or has broken into blood-vessels and spread to distant parts a neoplasm
is considered malignant. In the overwhelming majority of cases tumours having
these characteristics kill the bearer earlier or later. Thus the conceptions of
clinical and pathological malignancy are not at variance except for the relatively
few types of neoplasms, which are less dangerous than the unexperienced would
assume from their morphology.
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(a) Conditioned Growths.
One of the best examples of experimentally-induced tumours, which look
malignant under the microscope but biologically are not, are the tar-induced skin
tumours of the rabbit. Studying these neoplasms Rous and Kidd (1939) encoun-
tered a great variety of growths widely different in their morphology but uniform
in their behaviour. Some had the microscopical appearance of what they were,
namely benign neoplasms, but others had become anaplastic, had invaded the
deeper layers of the skin and sometimes were found inside lymphatics. Yet all,
except the frillhorns, regressed once tarring was left off. The papillomas faded
away and only the largest persisted because of their core, the covering epithelium
reverting to an apparently normal epidermis. The so-called carcinoids, i.e. the
neoplasms which looked like carcinoma, underwent differentiation to papillomas
after connective tissue had walled them off. Massive necrosis of a carcinoid
was seen only once. The same authors (1941) described two different processes
in regressing tumours, one characterized by proliferation of the connective tissue
coupled with inflammatory changes and another by atrophy of the tumour
epithelium with cell loss exceeding replacement. Mackenzie and Rous (1941)
have offered overwhelming evidence for the persistence of neoplastic cells in
apparently normal skin after what appeared to be complete regression, another
extreme situation showing the limitations of morphology. Two possibilities
exist: inability of the observer's eye to pick out a few abnormal cells among the
mass ofnormal elements or, as suggested by Rous and Kidd (1941), the neoplastic
epithelium resumes the appearance of the normal. The regression of these tar
tumours is due to the withdrawal of the stimulus which induced them and in the
absence of which they cannot maintain themselves. Therefore it is doubtful
whether the connective-tissue reaction found around regressing carcinoids is
different from processes of repair seen when non-neoplastic tissue has been des-
troyed by a vascular accident or by necrosis. Not every conditioned growth
undergoing regression provokes this reaction. In the rat prolonged administration
of oestrogens leads to a tumourous enlargement of the pituitary which regresses
as soon as the hormonal treatment ceases (Nelson 1944). First the cells forming
these " adenomas "become smaller, the large Golgi apparatus disappears and their
nuclei resemble those of the" wheel " cells of the ovary of the hypophysectomized
rat. Then the centre undergoes liquefaction and-finally few signs of their former
existence remain.
In human pathology where the etiology of a neoplasm is rarely known, one
cannot be sure whether regression ofa tumour might not be due to the withdrawal
of the inductive stimulus or to the elimination of a promoting factor essential for
the growth of the neoplasm. Were it not for the now many times observed
regression of carcinomas after administration of hormones one would have little
evidence that the body disposes ofagents capable ofopposing malignant growth.
(b) Malignant Growths.
Before reviewing the literature dealing with the morphology of human cancers
regressing under the influence of hormonal treatment it might be useful to dwell
shortly on some observations made on spontaneously regressing cancers of man
and on the findings of Foulds (1952) obtained in breast tumours of mice.
Since Virchow's days pathologists have been aware of degenerative processes
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in tumours and of the fibrous tissue reactions which accompany or follow these
phenomena. Handley (1909) believed that regressive changes in tumours start
always centrally and affect the oldest lesions first, and he described in detail the
obliteration of invaded lymphatics by fibrous tissue. From the older literature
only two other papers will be quoted. Erdheim (1930) described the repair of
metastatic lesions in bone in a case of metastasizing ovarian cancer which had
spread into many parts of the skeleton. Already at naked-eye inspection these
lesions differed from the ordinary. From a detailed study of many metastatic
foci in the bones Erdheim drew the following picture: retrogression of cancellous
tissue starts in foci, sometimes in the centre, occasionally in the periphery until
the greater part of the mass is involved. He distinguished two types, atrophy
and necrosis. In the case of the former the number of tumour units diminish,
their cells become pale and small, so that the stroma predominates and finally is
the only remaining element. In the latter case all elements, including cancellous
trabeculae situated in the metastasis, become necrotic. Mesenchymal elements
derived from the stroma of the tumour, i.e. originally from the reticulum of the
bone marrow, penetrate into the necrotic area while phagocytes remove the debris.
The whole area of necrosis is then replaced by scar tissue. Its fibres are delicate
and loosely knit, never assuming a scirrhus character. Sometimes cancer cells
situated in the tissue surrounding the bone try to re-invade it from outside. When
this happens the connective tissue which has replaced a necrotic metastasis
appears immune against this invasion. According to Erdheim (1930) the malig-
nant cells advancing against the scar grow like a benign adenoma, compressing
the scar tissue but never infiltrating it. Erdheim laid stress on the particular
quality of this connective tissue and of the phagocytes contained in it. He
expressed the belief that such scar tissue possesses a local immunity against
malignant growth. This paper has been quoted in extenso because it is one of the
few accounts known to the writer in which morphological evidence is offered
suggestive of a qualitative difference between ordinary connective tissue and the
stroma of tumours.
In Sampson's (1931) paper on the reaction of the peritoneum to the implanta-
tion of cancer cells of ovarian origin similar opinions are expressed. He compares
the reaction of the peritoneum to implanted tumour cells with that to an inert
foreign body. The cancer cells are enmeshed in fibrin which becomes organized
by ingrowing fibroblasts with or without the aid of vascular endothelium. The
granulation tissue can then be transformed into connective tissue encapsulating
the neoplastic cells. From the following quotation it will be seen that Sampson,
like Erdheim, believed in an acquired local immunity to malignant growth.
"Does the peritoneum ofpatients with peritoneal carcinomatosis actually develop
a relative immunity to the implantation of cancer on its surface? I believe that
this occurs in some instances."
The hypothesis of local or constitutional immunity, still expressed in the 1940
edition of Ewing's famous work, figures rarely in modern writing, but the concep-
tion of the important role of the stroma in tumour regression is very much alive,
as will be seen later.
Lastly, some unusual morphological findings from Sumner's (1953) afore-
mentioned case of regressing melanoma deserve a short description. Of special
interest are the changes in one ofthe lymph nodes removed from the groin. Here
lymphatic tissue was only present in the periphery of the node. The centre
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consisted ofdense hyaline fibrous tissue with an area ofcalcification. In oneregion
the connective tissue was more loosely arranged and contained malignant melan-
oma cells in different stages of degeneration together with plasma cells, lympho-
cytes and polymorphs in moderate numbers. The blood vessels had greatly
thickened fibrotic walls and a narrow lumen. On the basis of these findings the
pathologist assumed that the patient had received radiation treatment; however,
this was not the case.
The histological changes occurring in mammary cancers of mice which retro-
gress after parturition were followed by Foulds (1952). At the height of their
growth these neoplasms consist ofradiating ducts filled with epithelial cells, many
of them dividing. After parturition the neoplastic epithelium becomes des-
quamated and is apparently extruded by way of the ducts. At the same time
the stroma becomes denser and finally a compact fibrous tissue, rich in collagen,
compresses the duct-like structures. When these tumours resume their growth
collagen disappears and a loose stroma surrounds the growing tubules. Although
it is not known whether the regression is due to the withdrawal of a growth
promoter or to an inhibitory agent active after parturition, it is interesting to note
that inthese micethetumourepithelium aswellasthe stromaundergoes asequence
of changes which resemble those which can occur in cancers of the human breast.
3. Morphology ofInduced Regression.
(a) By oestrogens in mammary cancers.
Few papers describe in detail the histological changes induced by oestrogens
in mammary cancers. The first account was given by Koller (1944) in an adden-
dum to the famous paper of Haddow, Watkinson and Paterson (1944). Koller's
material came from a previously untreated spheroidal cell cancer of the breast
of a woman of 64 years of age. She received 15 mg. of stilboestrol weekly by
intramuscular route and in addition 1 mg. daily per os. The primary tumour
as well as the axillary lymph nodes diminished in size and the ulcerated skin
healed. Four biopsy specimens were taken in approximately monthly intervals,
the first before treatment started and the others during the period of clinical
regression. Originally the tumour contained 125-27-3 per cent of potentially
dividing cells and the division rate was 2.3, 5.2, 5.6 and 7.5 per cent in the four
areas studied. After one month the division rate did not surpass 4.6 per cent.
In addition new cytological features appeared, vacuolation ofnuclei, intensification
in the stainability of the cytoplasm and abnormal mitoses. Degenerated tumour
cells had increased from 2.5 to 12*5 per cent. The third specimen showed a very
similar picture, but in the fourth a new rise in mitoses was found; many ofthese,
however, were frankly abnormal. The number of degenerated cells reached
16.3 per cent. Koller interpreted his findings as an indication for primary
damage to the nucleus and for stilboestrol-induced breakdown in the mitotic
mechanism which became apparent in the fourth biopsy specimen.
Huguenin, Saracino and Gerard-Marchand (1951) described the reaction of
two mammary cancers to hexoestrol. One patient, a woman 73 years old,
suffered from an enormous, ulcerating and fungating cancer which had apparently
not spread to the axilla. The pre-treatment biopsy revealed a carcinoma ofpre-
dominantly glandular character, the tumnour cell acini being lined by cuboid
or cylindrical cells. In other areas, however, solid epithelial masses were found
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spreading into the loose connective tissue. The patient received 20 mg. ofhexoes-
trol for 9 days, 40 mg. for 53 and finally 60 mg. with excellent results. The next
biopsy was performed after 2260 mg. ofhexoestrol had been given. On the whole
the picture resembled that ofthe first; tumour cell acini surrounded by strands of
fine fibres were still present, but the cancer cells showed definite degenerative
changes. They were less well outlined, irregularities in chromatin content and
shape of the nuclei more pronounced and occasionally the nuclei seemed to break
up. These regressive changes were most advanced in the more isolated tumour
units accompanied by intense round cell infiltration of the stroma. Four weeks
later (3100 mg. hexoestrol) the tumour had become a scar with a small ulcer in the
centre. A specimen taken from this area showed only granulation tissue with
dilated capillaries and infiltrated by leukocytes, predominantly polymorphs.
Next to the ulcer healthy epidermis covered a scar tissue rich in collagen and round
cells. Six weeks later a fourth biopsy showed a further increase in the density
of the collagen, perivascular agglomeration of round cells still persisted and occa-
sionally minute calcium deposits were found in the section, but there was no
evidence for the presence of tumour cells.
The second patient, a woman of 74 years, had a recurrence in the breast
sixteen months after the primary growth had responded well to thermocautery
and X-ray treatment. It was an adenocarcinoma differing from the one described
above by growing in solid sheets, which were surrounded by a scanty connective
tissue. The tumour was well differentiated in parts, but contained also more
anaplastic areas with numerous mitoses and where invasion of blood vessels had
taken place. This patient received 20 mg. of hexoestrol for 12 days, 40 mg. for
3 weeks and 60 mg. for 2 months. After two months of therapy the morphology
of the carcinoma had changed into that of a quite atypical tumour. Where
larger accumulations of cancer cells persisted remnants of pseudoacini were still
recognizable; but the cells were less well defined and their nuclei pyknotic or
swollen. The stroma nowformedthepredominant part oftheneoplasm. Instead
ofinvasion ofthe connective tissue by the cancer cells mesenchymal cells seemed to
advance in between the tumour epithelium, a picture resembling that of a foreign
body reaction. Finally the dispersed tumour cells underwent lysis, sometimes
whole groups becoming necrotic and occasionally impregnanted with calcium.
A moderate inflammatory reaction accompanied these changes. When 60 mg.
ofhexoestrol had been given for two months only a small hard nodule remained in
the area formerly occupied by the tumour and the lymph nodes were not any more
palpable. A radical mastectomy was performed, but the wound healed so slowly
that a new recurrence was suspected. A biopsy showed granulation tissue, but
no tumour cells. It is ofinterest that a small squamous cell carcinoma ofthe face
remained stationary at the time the breast cancer regressed. The French authors,
althoughwell aware oftheregressive changes innucleiandcytoplasm ofthe tumour
cells, stress the importance of the stromal reaction. They believe that the epi-
thelium-connective tissue relationship is shifted in favour of the latter and see in
the sclerosis an active process and not a simple replacement fibrosis. Sirtori
and Grattavola (1947) investigated the reaction of the connective tissue to oes-
trogen. From experimental findings and from their own observations in man they
arrived at the following conclusions: Oestrogen stimulates the mesenchymal tissue
in general, but this stimulation is more pronounced in the breast than, for instance,
in the skin. As far as mammary cancers are concerned they state that the
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cytological changes observed in tumour cells under treatment with oestrogen do not run parallel with clinical findings and that they do not explain the softening ofthetumour, which is clinically so often the outstanding feature of retrogression. They interpret the beneficient effect of eostrogen therapy as due to a modification of the stroma around the tumour cell nests. It consists in the substitution of a sclerotic dense stroma by one which is loose, oedematous, rich in fibres and contains many histiocytes. They believe that the different response of pre- and post- menopausal women to oestrogen can be explained by the state of the tumour stroma. In the younger age group the stroma is already loose and cellular, whereas in the older women it is sclerotic. Only the latter will change under the influence of hormonal therapy. In a second well-illustrated communication Sirtori (1951) gives additional data. He describes the striking difference in the reactionofthemammary gland tissue of a young man to oestrogen and to androgen. The former induces proliferation of the connective tissue, i.e. hyperplasia and the latter sclerosis, considered to be a regressive condition. Sirtori found exactly the same changes in the stroma of mammary cancers after treatment with these two hormones and he considers them striking enough to allow a diagnosis of the agent used. Thus degenerative changes which adnmittedly occur in mammary cancercellsunder oestrogen treatment are, in Sirtori's opinion, less important than the activation of the stroma which takes place not only in the primary tumour
but also in the metastases.
Emerson, Kennedy, Graham and Nathanson (1953) have given themost comprehensive account ofthe changes which occur at the time of clinical regression inmammary cancers of patients treated with oestrogens. The core of their paper are observations on total mastectomy specimens from thirteen primary meta- stasizing tumours. Twelve of the patients were post-menopausal women and one was a man 54 years of age. His mammary cancer had regressed after orchidec- tomy and he was treated with stilboestrol when, eighteen monihs after the opera-
tion, the tumour showed renewed signs of growth. Like in the cases recorded by Huguenin, Saracino and Gerard-Marchand (1951) this publication provides histological evidence that under oestrogen treatment some mammary cancers undergo retrogressions of such an extent that one can speak of near complete
disappearance of the malignant cells from the primary focus as well as from the
axillary glands. At the same time the paper contains examples of discrepancies between the cardinal clinical sign of regression-softening of the tumour-and the
histological evidence indicating progression. Two main alterations in regressing
tumours were observed-loosening of the stroma and degenerative changes in the
cancer cells. The predominant change in the connective tissue occurring during
the first month oftreatment consisted in a reduction of the formerly dense collagen and its replacement by a loose tissue formed by narrow strands of collagen fibres
and by fibrocytes with large nuclei. Emerson and his collaborators compare this
loosening of the tumour stroma with the changes in the periductal connective
tissue of young women during pregnancy or in the pre-menstruum, and point out
that here, too, this process is limited to the connective tissue adjacent to epithelial
elements. In earlier phases of retrogression degenerating cancer cells, together with plasma cells and lymphocytes, were still present. Later on these cells
disappeared, new collagen as well as elastic fibres formed, so that in the end there
remained nothing but a fibrotic area formed by a sparsely cellular dense connective
tissue. The same end result as in the primary tumour could be observed in
105F. BIELSCHOWSKY
invaded lymph nodes. In the cases which responded best the lymph glands were
transformed into scar tissue in which a few degenerated cancer cells remained.
In regressing skin lesions the alterations in the connective tissue were less promi-
nent, but occasionally lymphatics were found obliterated by fibrotic plugs. The
degenerating tumour cells showed a swollen, pale or vacuolated cytoplasm, karyo-
lysis or pyknosis of nuclei and fragmentation or shrinkage of cells. Comparison
of the material obtained from patients with induced regression with that of 110
mastectomy specimens from breast cancer patients not previously treated revealed
that the magnitude of the changes found in the former was of quite a different
order. Foci of degenerating tumour cells and stromal changes of a similar char-
acter as described above were occasionally seen in the material from untreated
patients, but the areas so affected were never large enough to suggest a general
tendency for regression. Of interest is the observation that all but one of the
regressing cancers showed a marked hyperplasia ofthe elastic tissue prior to treat-
ment. This hyperplasia increased under the influence of oestrogens. Tumours
of low to medium malignancy with a tendency to fibrosis and hyperplasia of
elastic fibres were, in the experience of the American workers, most likely to show
a favourable response to oestrogen. Which of the two major alterations, degener-
ation of tumour cells or connective tissue changes, occurs first they were unable
to ascertain. There was no evidence that one preceded the other. They conclude
that the main effect ofthe hormone is to strengthen a pre-existent reactive response
ofthe connective tissue to the tumour and express the opinion '- that these regres-
sions were in part the result of an unusual hormonal stimulation of a natural
occurring process of repair".
It should be taken into account that the findings just discussed come from a
selected material, i.e. from cases showing unusual degrees of retrogression. This
may explain why.some authors were unable to discover consistent morphological
changes in breast cancers which clinically improved under oestrogen treatment
(Godwin and Escher, 1951; Dargent and Papillon, 1951).
A possible defensive role of the subepithelial connective tissue surrounding
mammary ducts filled with cancer cells has been proposed by several authors,
more recently by Bohle (1951). The findings of Huguenin, Sirtori and Emerson
et al. give substance to this hypothesis and offer at least suggestive evidence that a
defensive process against malignant growth can be set in motion by oestrogens in
certain cases of cancer of the breast.
(b) By oestrogens in prostatic cancers.
Schenken, Burns and Kahle (1942) were the first to give a well illustrated
account of the morphological changes occurring in prostatic cancers of patients
treated for periods of 25-46 days with stilboestrol or its dipropionate ester. (The
case histories are given in the paper of Kahle, Ogden and Getzoff, 1942.) The
principal findings in these biopsies were marked shrinkage of nuclei to about half
their former size and vacuolation of the cytoplasm in the tumour cells. Although
slight cytoplasmic vacuolation is not an unusual feature of prostatic cancer cells,
the degree observed after administration of synthetic oestrogens surpassed by a
wide margin what could be found in untreated patients. The figures 14-17 of
Schenken et al. (1942) paper give a clear picture of the different stages of cell
degeneration, ranging from pyknosis of nuclei and ballooning of the cytoplasm to
cell destruction, i.e. the formation of clear spaces having the shape of acini and
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containing only nuclear fragments. Groups of healthy-looking tumour cells
remained among the degenerating elements. Heckel and Kretschmer (1942)
observed similar degenerative changes in the prostatic cancer of a patient treated
with stilboestrol for 233 days. Fergusson and Pagel (1945) tried to assess quanti-
tatively the reduction in the number of tumour units as well as the coincident
decrease in nuclear size of neoplastic cells in five carcinomas of the prostate
which responded with retrogression to oestrogen therapy. Tumour cell counts
in a second biopsy specimen taken 10-30 months after commencement of treat-
ment showed that their numbers had declined to one-third to one-sixth ofthe pre-
treatment values. In three cases the nuclear diameter was significantly smaller.
To judge from the photomicrographs the stroma increased in amount and density
during the period of treatment. The paper describes and depicts also the dis-
appearance of acid phosphatase from metastatic tumour cells after 24 days of
administration of dienoestrol. Continuing these investigations Fergusson and
Franks (1953) noted that already one week after the onset of treatment regressive
changes were recognizable in the prostatic cancer cells, vacuolation of the cyto-
plasm being the first sign. The affected cells increased in size, assumed the shape
of signet cells and their nuclei became denser or, occasionally, vacuolated. Des-
quamation and rupture of the neoplastic cells were the end result of this process.
At the same time the stroma became imbued with products of disintegration and
converted into a loose, fibrillar, ill-defined tissue which had an affinity for basic
dyes. Replacement fibrosis was sometimes seen at a later stage. In two cancers
squamous metaplasia was observed, once in the primary tumour and once in a
metastic nodule situated in the liver-possibly a reaction of the tumour cells to
oestrogen similar to that of the normal transitional epithelium of the prostatic
urethra. Although each type of prostatic cancer cell-the authors distinguishing
between a clear orreticular, a dark basophilic and ananaplastic type with vesicular
nucleus-showed approximately equal sensitivity to oestrogen, the dark elements
were found more frequently among the surviving cancer cells, present in all speci-
mens.
From these observations it appears that in the case ofprostatic carcinoma the
reaction to oestrogen is far less complex than in mammary cancers and, what
facilitates the interpretation, the first changes appear after a remarkably short
interval. Fergusson and Franks (1953) refer to observations oftheir own in which
the neoplastic cells were already affected by oestrogen after less than 24 hours,
a period shorter than that needed for the induction ofoestrus in a gonadectomized
rodent. These findings are, in the writer's opinion, highly suggestive for a direct
effect of the hormone on the neoplastic cell.
Quite a different type of regression was seen by Franks (1953) in a case of
prostatic cancer. Since treatment with large doses of stilboestrol had failed to
influence pain and dysuria in the 63-years-old diabetic patient, adrenalectomy was
performed. No immediate clinical improvement followed the operation and stil-
boestrol therapy was reinstituted. Death occurred on the 40th post-operative
day in consequence of an infarction in the lung. The post-mortem examination
revealed the presence of a large carcinoma of the prostate which had invaded
the seminal vesicles and the bladder. Metastases were found in liver, lungs and
in many abdominal and mediastinal lymph nodes. Histologically the primary
tumour as well as all the secondaries showed massive central necrosis, surrounded
by a rim of apparently viable tumour. The two zones were separated by granu-
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lation tissue. The central necrosis involved tumour cells as well as stroma, and
even some of the larger blood vessels There was a gradation in the intensity of
the degenerative changes, which reached the maximum in the centre. From the
study of small metastatic foci in which the blood vessels were not affected Franks
concluded that the primary effect had been on the tumour cells. This case pro-
vides good morphological evidence for acute systemic regression in a primary
cancer and its metastases without active participation of the stroma.
The factors responsible for the destruction of this widely metastasizing neo-
plasm cannot be easily assessed. However, it seems possible that the large doses
of stilboestrol given were of greater importance than the adrenalectomy. Some
support for this contention comes from Baker's (1953) observations on two
patients, the metastatic pain of which was not ameliorated by oestrogen prior
to but after adrenalectomy. Whereas an increased and sometimes even fatal
androgen effect after adrenalectomy is a well-established fact, no corresponding
data exist so far in the case of oestrogens.
In prostatic smears from patients treated with oestrogens Peters (1950)
found regularly large highly vacuolated cells, the apparently empty cytoplasm
of which was in fact filled with glycogen. These epithelial elements disappeared
rapidly from the smear when hormone therapy was withheld. According to
Peters these glycogen-rich cells are non-neoplastic and easily distinguishable
from carcinoma cells, which are shrunken, have poorly stainable nuclei and can
disappear under oestrogen treatment (Peters and Frank, 1952). Papanicolaou
(1949), however, mentions that not only normal but also prostatic cancer cells
may show cellular and nuclear enlargement under these conditions. I have been
unable to find any reference to the glycogen content of the vacuolated neoplastic
cells characteristic for an oestrogen senstive prostatic carcinoma. The pictures
of Peters (1950) resemble so much the balloon cells of Schenken et al. (1942) and
of Fergusson and Franks (1953) that it seems worthwhile to investigate whether
the neoplastic prostatic epithelium accumulates glycogen under the influence of
oestrogen.
(c) Byprogesterone in cancer of the cervix.
Hertz, Cromer, Young and Westfall (1951) discovered that some carcinomas of
the cervix of pre- and post-menopausal women regressed under progesterone
treatment. Platt (1952) gave a description of the morphological changes noted
in cervical smears and in biopsy specimens obtained from these patients. In
cases responding favourably a change in the composition and cytology ofthe smear
was already recognizable at the third day of progesterone administration.
Blood and cellular debris diminished and normal squamous epithelial cells became
more numerous. The cancer cells increased in size, their nuclei losing the com-
pact and assuming a more granular appearance. The same trend was also seen
in sections of the tumours. In a few patients cancer cells disappeared completely
from the smear and post-treatment biopsies failed to reveal the presence of
epidermoid carcinoma. A comparison of pre- and post-treatment tissue sections
stained with Best's carmine disclosed differences in "glycogen "content of normal
and neoplastic squamous epithelium. In post-treatment specimens less glycogen
was found in the nuclei and hardly any in the cytoplasm; but an accumulation
of intercellular carmine-positive material was noted together with increased
amounts of fluid. Platt mentions that similar effects of progesterone were seen
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in one case of squamous cell carcinoma of the vulva. It seems desirable to
check the shift of the Best carmine-positive material with more specific staining
methods.
(d) By other means.
Literature on the morphology of testoterone-induced regressions of mammary
cancers is practically non-existent. Adair and Hermann (1946) quote in their
paper the reports of Fred Stewart on the biopsies of two of their cases which re-
gressed under testosterone treatment. The material came from metastatic skin
nodules. "Rather marked focal hydropic degeneration, mitoses still present"
and " cells definitely hydropic and nuclei pyknotic. Rare mitoses still seen.
The tumour shows distinct differences from the expected." I do not know of any
comprehensive study which confirms or refutes Sirtori's (1951) findings of the
sclerotizing action of androgens on the stroma of mammary cancers. Apparently
testosterone affects more frequently metastases to the bone, and many excellent
X-ray photographs testify to the far-reaching regressions they can undergo under
androgen treatment. However, lesions which on radiological evidence appear
completely healed can contain still considerable amounts of viable tumour, as
revealed by post-mortem studies (Preston, Taylor and Crumrine, 1949).
Although excellent descriptions of clinical regressions of mammary cancer
in man after orchidectomy are available (Treves, Abels, Woodard, and Farrow,
1944; Treves 1949) the corresponding morphological changes have not yet been
fully described, and the same scarcity of data exists for tumours regressing after
adrenalectomy and hypophysectomy.
Emerson et al. (1953) mention the alterations in an adenocarcinoma of the
breast in a middle-aged man after orchidectomy. Three biopsies taken during
the period of post-operative regression revealed degenerative changes of quite
considerable extent, but already, six months after orchidectomy, foci of less
differentiated carcinoma were discovered in a lymph node.
Luft and Olivecrona (1953) depict the changes which occurred in a typical
gelatinous mammary cancer following hypophysectomy. Before the operation
the amount of colloid was moderate and epithelial elements predominated. Four
months after the operation few groups of malignant cells remained and the
mucoid material was abundant. Five months later only isolated cancer cells
were present, there was less mucoid material and the connective tissue had
increased. Histological examination of several organs of a hypophysectomized
patient who had died of malignant melanoma (Shimkin, Boldrey, Kelly, Bierman,
Ortega and Naffziger, 1952) revealed some unusual features in metastatic nodules
situated in liver and spleen. The two "secondaries" in the liver were found to
consist of a dense collagenous scar tissue containing pigment granules, but no
tumour cells. In the spleen the metastases had a hyalinized or necrotic centre and
even in the periphery there was a considerable amount of fibrous tissue. Here the
tumour cells appeared degenerated, some had hydropic nuclei, others were remark-
ably small and appeared shrunken. On the other hand, no morphological evidence
for regression was found in the metastases in jejunum, lymph glands and lungs.
4. Changes in Endocrine Organs of Patients Sufferingfrom Malignant Disease.
Surgical removal of the gonads, the adrenals and the pituitary has been
performed with the intention of arresting the progress and spread of cancers which
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could no longer be controlled by other means. Since the earliest days of this
century, when British surgeons were well aware of the benefit of ovariectomy in
some cases of mammary cancer, progress has been slow in the understanding why
the response to the operation varied so greatly. Already in 1900 Boyd suggested
"that certain ovaries, probably by pathological variation in their internal secre-
tion, favour the growth of cancer by action either upon the growth or upon the
tissues; the removal ofsuch ovaries alone will be ofbenefit ". Progress has come
from the study ofthe ovaries and secondary sex organs ofpost-menopausal women.
The old conception of a functionally inactive gland has given way to the recog-
nition that the ovary can secrete oestrogens for considerable periods after menstru-
ation has ceased. Examination of vaginal smears showed that in many post-
menopausal women the mucosa is far from being atrophic and the same applies
to the endometrium. In 1941 Smith called the attention to abnormalities in the
post-menopausal ovary of women with endometrial cancer. Instead of a narrow
cortex rich in collagen he found a wide cellular outer zone. These changes
occurred more often in cases of cancer of the corpus uteri than in normal women.
A later study by Woll, Hertig, Smith and Johnson (1948) confirmed and enlarged
Smith's previous findings. The main features of the condition they described
and named thecomatosis were nodular masses of plump cells, which had an
enlarged nucleus and prominent nucleolus and dipped deep into the stroma.
Sometimes areas of epithelial-like lipoid-containing cells were also present and
were considered to be luteinized theca cells. The publications of Laffargue,
Luscan and Lavernhe (1952) and of Dockerty, Lovelady and Foust (1951) contain
confirmatory findings. Very similar changes in combination with medullary
vascular hyperplasia were found by Sommers and Teloh (1952) in 83 per cent of
patients which had died of carcinoma of the breast and in 37-6 per cent of controls.
A high degree ofhyperplasia occurred only once in the non-cancer group. McManus
and Sommers (1952) found that women with ovaries showing thecomatosis at
the time they were surgically removed had a longer survival time than patients
with atrophic ovaries. In the latter group of breast cancer patients the post-
castration survival was so short that the authors consider the possibility whether
ovariectomy had not produced actual harm. Burt and Castleman (1953) also
observed a high incidence ofovarian stromal hyperplasia in women with carcinoma
of the breast.
The findings of Sommers and his associates might provide an explanation for
some extraordinary post-castration regressions. Raven (1950) reported a remark-
able case ofmetastasizing spheroidal cell carcinoma of the breast which retrogressed
after ovarietomy to such an extent that two years after the operation no signs
of malignant disease were detectable. In one of the ovaries of this patient the
pathologist found a wide, ill-defined zone of theca cell formation.
As far as the testes are concerned they do not show specific changes in either
cancer of the breast or of the prostate. In the adrenals of some of their patients
with advanced mammary cancers Huggins and Dao (1953) found evidence for
hyperplasia especially marked in the zona glomerulosa. Burt and Castleman
(1953), too, noted that the average adrenal weight in women with cancer of the
breast exceeds that of adrenals from patients without carcinoma. These authors
gave the only modern description of the cytology of the adenohypophysis in
malignant disease of the breast. They found an increase in the basophils and in
the hypertrophic amphophils, an abnormality not specific for mammary cancer.
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This important paper contains interesting observations on the effect of oestrogens
on the human pituitary.
Of the morphological investigations reviewed above only those on the ovaries
have contributed so far to our understanding of malignant disease. There seems
to be a definite need for more information, not only on the pathology ofthe ovaries
but specially of the pituitary, adrenals and testes.
5. Discussion.
The findings presented in the section on hormone-induced regression will, it
is hoped, be accepted as evidence that physiological agents can influence pro-
foundly some malignant growths. It could be argued that the therapeutic results
obtained are due to the administration of pharmacological doses and therefore
should not be used as evidence for a naturally occurring hormonal defence mech-
anism. Actually the amounts of oestrogen needed for arrest of a susceptible
carcinoma of the prostate are rather small. Using the level of serum aldolase,
or of acid phosphatase as indicator, Baker and Govan (1953) and Baker et al.
(1953) found doses of 0.25-0.5 mg. effective. Similar amounts control the
symptoms of the menopause without inducing hyperplasia of the endometrium.
Thus they do not fall outside the physiological range. Admittedly sometimes
much higher doses are needed to influence malignant growth. In systematic
studies over twenty years Lipschutz (1950) and his pupils have firmly established
the quantitative relationship between tumour growth-promoting steroids and
those opposingit. Lipschutz (1952, 1954) hasdrawn attention tothe dangerwhich
may result when rhythmic processes are converted into continuous ones and sees
in the rhythmic release of ovarian hormone one of the means of "antitumoural
auto-defence". As far as the amounts of steroid needed for tumourigenesis are
concerned he found them to be much smaller than was believed previously; in
fact, physiological amounts, acting unopposed, could induce neoplastic growth.
With increasing knowledge of the natural history of tumours responding to
hormonal action the gap between clinical and the experimental findings of the
Chilean workers has narrowed.
Stewart (1952) has recently recorded his experiences in spontaneous regression
of neoplasms. He considers the disappearance of in situ epidermoid carcinoma
of the uterine cervix a distinct possibility, an opinion shared by other students of
this condition (Reagan, 1952; Hoffman, Farell and Hahn, 1953). After the dem-
onstration of the beneficial effect of progesterone on such or even more advanced
lesions (Platt, 1952) one could envisage a shift of a disturbed steroid hormone
balance towards predominance of the corpus luteum hormone as a possible mech-
anism for retrogression of these neoplasms. Slight variations in hormone level
might also account for the appearance of late metastases of hormone dependent
tumours.
6. Regressions Induced by Immunological Reactions.
Stewart's (1952) paper contains a unique observation. A patient suffering
from myosarcoma of the uterus reacted to irradiation with what resembled an
anaphylactic reaction and the inoperable tumour disappeared in the course of a
few days. Five years later she was again treated with radium for a lesion of the
cervix. Again high fever, an urticarial rash and eos'minophilia appeared, proofthat
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the first reaction and the regression of the tumour were not due to specific sensi-
tization against the cancer. There is little evidence that antibodies elicited by a
neoplasm have ever produced enough tumour-specific antigens to induce its des-
truction (Hauschka, 1952). However, immunogenetical reactions may play a
role in the regression of choriocarcinomas. This malignant growth of foetal
origin could provoke an antigenic response when invading maternal tissue. Two
facts support this hypothesis. Park and Lees (1950) on the basis of an analysis
of 516 cases of choriocarcinoma conclude: "True regressions occur in a small but
certainly significant proportion of cases ". Late recurrences, if they occur at all,
are extremely rare as compared with carcinoma ofthe breast. The authors state:
"Choriocarcinoma kills either within 12 months ofdiagnosis or not at all", a most
unusual behaviour for a malignant growth. The high death-rate from chorio-
carcinoma recorded in the older literature was probably wrongly ascribed to the
malignant properties of the tumour itself. The mortality from choriocarcinoma
seems to have declined in the last decades since blood transfusion and chemo-
therapy have lowered the risk of death from haemorrhages and puerperal sepsis.
When these complications were eliminated astonishingly high survival rates
resulted. They cannot be dismissed with the assumption that the condition was
overdiagnosed. For instance in a series of 22 cases described by Huber and
H6rmann (1952) there were 19 survivors, in 6 ofwhich metastases hadbeenpresent.
These observations may be taken as an indication that apart from hormones
other, not yet identified, bodily agents may be able to induce regression in malig-
nant growths.
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